X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (5644) 5644
Publication (730) 730
Newsletter (100) 100
Book Review (83) 83
Book Chapter (35) 35
Magazine Article (19) 19
Conference Proceeding (9) 9
Trade Publication Article (4) 4
Web Resource (4) 4
Data Set (3) 3
Dissertation (3) 3
Newspaper Article (3) 3
Book / eBook (1) 1
Government Document (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (3558) 3558
ribavirin (2808) 2808
index medicus (2431) 2431
pharmacology & pharmacy (2321) 2321
antiviral agents - pharmacology (1727) 1727
antiviral agents - therapeutic use (1707) 1707
male (1455) 1455
ribavirin - pharmacology (1453) 1453
female (1431) 1431
hepatitis c (1420) 1420
ribavirin - therapeutic use (1357) 1357
hepatitis c, chronic - drug therapy (1331) 1331
animals (1203) 1203
interferon (1126) 1126
hepatitis c virus (1116) 1116
middle aged (1090) 1090
hepacivirus - drug effects (1052) 1052
drug therapy, combination (1025) 1025
adult (1017) 1017
virology (998) 998
interferon-alpha - therapeutic use (876) 876
hepacivirus - genetics (830) 830
antiviral agents (812) 812
infection (788) 788
treatment outcome (785) 785
plus ribavirin (746) 746
infectious diseases (735) 735
hepatitis c - drug therapy (725) 725
therapy (717) 717
genotype (671) 671
health aspects (642) 642
hepatitis (633) 633
gastroenterology & hepatology (632) 632
viruses (632) 632
antiviral agents - administration & dosage (626) 626
virus-infection (617) 617
virus replication - drug effects (595) 595
recombinant proteins (582) 582
ribavirin - administration & dosage (571) 571
virus diseases (570) 570
microbiology (505) 505
interferon-alpha - pharmacology (494) 494
hepatitis c, chronic - virology (491) 491
aged (487) 487
hcv (472) 472
polyethylene glycols - therapeutic use (470) 470
antiviral agents - adverse effects (466) 466
drug therapy (465) 465
mice (464) 464
chronic hepatitis-c (448) 448
cell line (447) 447
replication (437) 437
biological response modifiers (419) 419
infections (405) 405
care and treatment (402) 402
analysis (399) 399
liver (361) 361
combination therapy (355) 355
sustained virological response (350) 350
interferon-alpha - administration & dosage (349) 349
dose-response relationship, drug (347) 347
rna (338) 338
immunology (335) 335
in-vitro (329) 329
research (323) 323
pegylated interferon (321) 321
ribavirin - adverse effects (321) 321
ribavirin - analogs & derivatives (317) 317
viral load (315) 315
combination (304) 304
peginterferon (300) 300
time factors (298) 298
antiviral activity (293) 293
peginterferon alpha-2a (290) 290
genetic aspects (278) 278
telaprevir (274) 274
research article (271) 271
patients (270) 270
hepatitis c - virology (268) 268
virus (264) 264
risk factors (259) 259
sofosbuvir (257) 257
biochemistry & molecular biology (255) 255
chemistry, medicinal (255) 255
hepacivirus - physiology (255) 255
digestive system diseases (253) 253
pharmacokinetics (252) 252
interferon-alpha - adverse effects (250) 250
antiviral agents - chemistry (246) 246
antiviral agents - pharmacokinetics (242) 242
cirrhosis (242) 242
medicine (241) 241
dosage and administration (236) 236
recombinant proteins - therapeutic use (236) 236
antiviral therapy (235) 235
interferons - therapeutic use (227) 227
hiv (226) 226
ribonucleosides - pharmacology (226) 226
viral nonstructural proteins - antagonists & inhibitors (226) 226
efficacy (225) 225
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5573) 5573
Russian (69) 69
Spanish (47) 47
Japanese (32) 32
Chinese (25) 25
Polish (18) 18
French (17) 17
German (6) 6
Hungarian (5) 5
Dutch (3) 3
Portuguese (3) 3
Serbian (2) 2
Arabic (1) 1
Bulgarian (1) 1
Italian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Mayo Clinic Proceedings, ISSN 0025-6196, 2011, Volume 86, Issue 10, pp. 1009 - 1026
Abstract Most viral diseases, with the exception of those caused by human immunodeficiency virus, are self-limited illnesses that do not require specific... 
Internal Medicine | MEDICINE, GENERAL & INTERNAL | HERPES-SIMPLEX-VIRUS | TENOFOVIR DISOPROXIL FUMARATE | PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY | ORGAN TRANSPLANT RECIPIENTS | POSITIVE CHRONIC HEPATITIS | CHRONIC HEPATITIS-B | ALPHA-2A PLUS RIBAVIRIN | OF-THE-LITERATURE | RECURRENT GENITAL HERPES | HIV-INFECTED PATIENTS | Acyclovir - therapeutic use | Foscarnet - pharmacology | Hepatitis C - drug therapy | HIV Infections - epidemiology | Humans | Ganciclovir - analogs & derivatives | Interferons - therapeutic use | Oligopeptides - therapeutic use | Hepatitis - drug therapy | Adenine - therapeutic use | Lamivudine - therapeutic use | Ganciclovir - therapeutic use | Proline - pharmacology | Protease Inhibitors - therapeutic use | Guanine - therapeutic use | Oseltamivir - pharmacology | Virus Replication - drug effects | Antiviral Agents - pharmacology | Adenine - analogs & derivatives | Organophosphonates - therapeutic use | Proline - analogs & derivatives | Antiviral Agents - therapeutic use | Comorbidity | Interferons - pharmacology | Pyrimidinones - therapeutic use | Acyclovir - pharmacology | Zanamivir - therapeutic use | Herpesviridae Infections - drug therapy | Thymidine - analogs & derivatives | Valine - therapeutic use | Oligopeptides - pharmacology | Ribavirin - pharmacology | Guanine - analogs & derivatives | Oseltamivir - therapeutic use | Guanine - pharmacology | Hepatitis C - epidemiology | Nucleosides - pharmacology | Ganciclovir - pharmacology | Pyrimidinones - pharmacology | Influenza, Human - drug therapy | Drug Therapy, Combination | Nucleosides - therapeutic use | Acyclovir - analogs & derivatives | Ribavirin - therapeutic use | Valine - analogs & derivatives | Zanamivir - pharmacology | Adenine - pharmacology | Proline - therapeutic use | Organophosphonates - pharmacology | Hepatitis B, Chronic - drug therapy | HIV Infections - drug therapy | Lamivudine - pharmacology | Foscarnet - therapeutic use | Valine - pharmacology | Amantadine - pharmacology | Antiviral agents | Diagnosis | Research | Drug therapy | HIV infection | Health aspects | Symposium on Antimicrobial Therapy
Journal Article
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 11/2012, Volume 56, Issue 11, pp. 5728 - 5734
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 03/2013, Volume 57, Issue 3, pp. 1312 - 1322
Journal Article
Clinical Pharmacokinetics, ISSN 0312-5963, 2014, Volume 53, Issue 5, pp. 409 - 427
Journal Article
Hepatology, ISSN 0270-9139, 2008, Volume 48, Issue 6, pp. 1769 - 1778
Journal Article
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 02/2014, Volume 58, Issue 2, pp. 647 - 653
Journal Article